A detailed history of Adar1 Capital Management, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 12,955 shares of VTYX stock, worth $28,630. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,955
Previous 5,000 159.1%
Holding current value
$28,630
Previous $27.5 Million 8.82%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.31 - $5.59 $18,376 - $44,468
7,955 Added 159.1%
12,955 $29.9 Million
Q1 2024

May 15, 2024

SELL
$1.9 - $10.13 $15,200 - $81,040
-8,000 Reduced 61.54%
5,000 $27.5 Million
Q4 2023

Feb 14, 2024

BUY
$2.08 - $31.18 $27,040 - $405,340
13,000 New
13,000 $32.1 Million

Others Institutions Holding VTYX

About Ventyx Biosciences, Inc.


  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $125M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.